t
Assura plc announced the results of its Annual General Meeting (AGM) held on 30 September 2025, where 3,193,912,732 votes were cast, representing 98.08% of its issued share capital. Shareholders passed 14 of the 18 proposed resolutions, specifically resolutions 1-12, 17, and 18, with 'For' votes generally exceeding 99%. Resolutions 13-16, pertaining to share allotment and market purchases, were not passed, receiving 'For' votes between 0.39% and 0.81%, as Primary Health Properties PLC stated they were not required.
| Date | 30 Sept 2025 |
| Time | 15:30:00 |
| Category | AGMs and other meetings |
| ID | 4645B |
30 September 2025
Assura plc ("Assura" or the "Company")
Result of AGM
Following its annual general meeting ("AGM") held today, Assura announces the results of the poll vote for each of the resolutions submitted to the meeting (as set out in the Notice of the AGM dated 5 September 2025). All resolutions except for resolutions 13 to 16 were passed as Primary Health Properties PLC decided they were not required at the current time.
|
Resolution |
For |
% For |
Against |
% Against |
Total Votes Cast (% of issued share capital) |
Votes Withheld |
|
1. To receive the Company's annual report and accounts |
3,191,210,029 |
99.92 |
2,702,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
2. To approve the Directors' Remuneration Policy |
3,191,198,870 |
99.92 |
2,713,862 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
3. To approve the Directors' Remuneration Report |
3,191,196,870 |
99.92 |
2,714,809 |
0.08 |
3,193,911,679 (98.08) |
25,609 |
|
4. To re-appoint Ernst & Young LLP as auditor of the Company |
3,191,210,029 |
99.92 |
2,702,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
5. To authorise the Audit Committee to determine the auditor's remuneration |
3,191,210,029 |
99.92 |
2,702,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
6. To re-elect Jonathan Murphy as a Director of the Company |
3,191,208,029 |
99.92 |
2,704,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
7. To re-elect Jayne Cottam as a Director of the Company |
3,191,208,029 |
99.92 |
2,704,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
8. To re-elect Louise Fowler as a Director of the Company |
3,190,442,909 |
99.89 |
3,469,823 |
0.11 |
3,193,912,732 (98.08) |
24,556 |
|
9. To re-elect Jonathan Davies as a Director of the Company |
3,189,424,843 |
99.86 |
4,487,889 |
0.14 |
3,193,912,732 (98.08) |
24,556 |
|
10. To re-elect Samantha Barrell as a Director of the Company |
3,190,440,909 |
99.89 |
3,471,823 |
0.11 |
3,193,912,732 (98.08) |
24,556 |
|
11. To re-elect Emma Cariaga as a Director of the Company |
3,191,210,029 |
99.92 |
2,702,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
12. To re-elect Noel Gordon as a Director of the Company |
3,191,185,999 |
99.91 |
2,726,733 |
0.09 |
3,193,912,732 (98.08) |
24,556 |
|
13. To authorise the Directors to allot shares |
24,777,490 |
0.78 |
3,169,134,189 |
99.22 |
3,193,911,679 (98.08) |
25,609 |
|
14. To authorise the Directors to disapply pre-emption rights |
13,632,718 |
0.43 |
3,180,279,914 |
99.57 |
3,193,912,632 (98.08) |
24,656 |
|
15. To authorise the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment |
12,529,192 |
0.39 |
3,181,382,387 |
99.61 |
3,193,911,579 (98.08) |
25,709 |
|
16. To authorise the market purchase of the Company's own shares |
25,792,609 |
0.81 |
3,168,120,123 |
99.19 |
3,193,912,732 (98.08) |
24,556 |
|
17. To authorise re-registration of the Company as a private company and adopt new articles of association |
3,191,208,029 |
99.92 |
2,704,703 |
0.08 |
3,193,912,732 (98.08) |
24,556 |
|
18. To authorise the Company to call any general meeting, other than an annual general meeting, by not less than 14 clear days' notice |
3,190,267,614 |
99.89 |
3,645,118 |
0.11 |
3,193,912,732 (98.08) |
24,556 |
Resolutions 1 to 12 were passed as ordinary resolutions. Resolutions 17 and 18 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman.
Notes:
1. The percentages above are rounded to two decimal places.
2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.
3. The total number of Assura ordinary shares in issue as at 6.00 pm on 26 September 2025, the time by which shareholders who wanted to vote at the AGM must have been entered on the Company's register of members, was 3,256,393,191 and the total number of voting rights in the Company was also 3,256,393,191.
Copies of resolutions 17 and 18, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
- Ends -
For more information, please contact:
|
Assura plc |
Tel: 0161 515 2043 |
|
Orla Ball, General Counsel David Purcell, Investor Relations Director
|
Email: [email protected] |
|
FGS Global Gordon Simpson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.
A UK REIT based in Altrincham, Assura is currently a constituent of the EPRA* index and has a secondary listing on the Johannesburg Stock Exchange. As at 31 March 2025, Assura's portfolio was valued at £3.1 billion and has a strong track record of growing financial returns and dividends for shareholders.
At Assura we BUILD for health and as a certified B Corp we are committed to keeping ESG as the heart of our strategy, creating Healthy Environments (E), Healthy Communities (S) and maintaining a Healthy Business (G).
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.